Entia Biosciences Stock Market Value

ERGO Stock  USD 0.0002  0.00  0.00%   
Entia Biosciences' market value is the price at which a share of Entia Biosciences trades on a public exchange. It measures the collective expectations of Entia Biosciences investors about its performance. Entia Biosciences is selling at 2.0E-4 as of the 12th of December 2024; that is No Change since the beginning of the trading day. The stock's open price was 2.0E-4.
With this module, you can estimate the performance of a buy and hold strategy of Entia Biosciences and determine expected loss or profit from investing in Entia Biosciences over a given investment horizon. Check out Entia Biosciences Correlation, Entia Biosciences Volatility and Entia Biosciences Alpha and Beta module to complement your research on Entia Biosciences.
Symbol

Please note, there is a significant difference between Entia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Entia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Entia Biosciences 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Entia Biosciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Entia Biosciences.
0.00
11/12/2024
No Change 0.00  0.0 
In 30 days
12/12/2024
0.00
If you would invest  0.00  in Entia Biosciences on November 12, 2024 and sell it all today you would earn a total of 0.00 from holding Entia Biosciences or generate 0.0% return on investment in Entia Biosciences over 30 days. Entia Biosciences is related to or competes with Heron Therapeuti, OUTLOOK THERAPEUTICS, Protalix Biotherapeutics, and Hookipa Pharma. Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals,... More

Entia Biosciences Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Entia Biosciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Entia Biosciences upside and downside potential and time the market with a certain degree of confidence.

Entia Biosciences Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Entia Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Entia Biosciences' standard deviation. In reality, there are many statistical measures that can use Entia Biosciences historical prices to predict the future Entia Biosciences' volatility.
Hype
Prediction
LowEstimatedHigh
0.000.000112.50
Details
Intrinsic
Valuation
LowRealHigh
0.000.000112.50
Details
Naive
Forecast
LowNextHigh
0.0000040.000212.50
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00020.00020.0002
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Entia Biosciences. Your research has to be compared to or analyzed against Entia Biosciences' peers to derive any actionable benefits. When done correctly, Entia Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Entia Biosciences.

Entia Biosciences Backtested Returns

Entia Biosciences is out of control given 3 months investment horizon. Entia Biosciences secures Sharpe Ratio (or Efficiency) of 0.13, which denotes the company had a 0.13% return per unit of risk over the last 3 months. We were able to analyze and collect data for seventeen different technical indicators, which can help you to evaluate if expected returns of 1.56% are justified by taking the suggested risk. Use Entia Biosciences Mean Deviation of 2.98, variance of 151.52, and Standard Deviation of 12.31 to evaluate company specific risk that cannot be diversified away. Entia Biosciences holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -3.14, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Entia Biosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Entia Biosciences is expected to outperform it. Use Entia Biosciences jensen alpha and day median price , to analyze future returns on Entia Biosciences.

Auto-correlation

    
  0.00  

No correlation between past and present

Entia Biosciences has no correlation between past and present. Overlapping area represents the amount of predictability between Entia Biosciences time series from 12th of November 2024 to 27th of November 2024 and 27th of November 2024 to 12th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Entia Biosciences price movement. The serial correlation of 0.0 indicates that just 0.0% of current Entia Biosciences price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0

Entia Biosciences lagged returns against current returns

Autocorrelation, which is Entia Biosciences pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Entia Biosciences' pink sheet expected returns. We can calculate the autocorrelation of Entia Biosciences returns to help us make a trade decision. For example, suppose you find that Entia Biosciences has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Entia Biosciences regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Entia Biosciences pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Entia Biosciences pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Entia Biosciences pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Entia Biosciences Lagged Returns

When evaluating Entia Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Entia Biosciences pink sheet have on its future price. Entia Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Entia Biosciences autocorrelation shows the relationship between Entia Biosciences pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Entia Biosciences.
   Regressed Prices   
       Timeline  

Pair Trading with Entia Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Entia Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entia Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Entia Pink Sheet

  0.77NVO Novo Nordisk ASPairCorr
  0.77REGN Regeneron PharmaceuticalsPairCorr
  0.76SGEN Seagen IncPairCorr
  0.75NONOF Novo Nordisk ASPairCorr
  0.7QSAM Qsam BiosciencesPairCorr
The ability to find closely correlated positions to Entia Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Entia Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Entia Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Entia Biosciences to buy it.
The correlation of Entia Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Entia Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Entia Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Entia Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Entia Pink Sheet

Entia Biosciences financial ratios help investors to determine whether Entia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entia with respect to the benefits of owning Entia Biosciences security.